Protein Purification and Isolation Market (2025-2032)

Protein purification is a process that isolates and purifies a single protein or protein complex from tissues, cells, or entire organisms. This process is essential for determining the cells' function, structure, and interactions of a protein of interest. Protein isolation helps understand the protein’s size, biological activity, binding affinity, protein-protein interaction, and physiochemical properties. Protein purification and isolation are done using various technologies such as precipitation, ultrafiltration, chromatography, and electrophoresis.

The growth of the protein purification and isolation market is driven by the growing need to identify new protein-based drug molecules, rising research in pharmaceutical and biopharmaceutical fields, and increasing focus on precision medicine. The increasing demand for protein therapeutics and rising spending on R&D in pharmaceutical and biotechnology industries are creating opportunities for the growth of this market.

Market players are focusing on developing innovative technologies for protein purification. For instance, in January 2022, QIAGEN N.V. (Germany) launched its QIAwave product line, which includes three nucleic acid extraction kits with fewer components. These products were developed to overcome the persistent problem of laboratory waste that scientists worldwide experience. These methods isolate and process DNA, RNA, and proteins from blood, tissues, and other sources. Compared to QIAGEN’s standard kits, these kits utilize up to 63% less plastic and 42% less cardboard.

In April 2021, Thermo Fisher Scientific Inc. (U.S.) launched its KingFisher Apex Purification System, a high-protein sample purification instrument for scientists to extract DNA, proteins, and cells. This system helps in protein and cell isolation and offers a highly customized process for adaptable, reproducible, and quick sample preparation at no extra cost. It generates error-free reports and high-quality nucleic acids and proteins with the help of automation technology. This protein purification device can process 24 to 96 samples in 25 to 65 minutes.

Increased government spending on R&D and initiatives to strengthen pharmaceutical and biotechnology sectors contribute to the growth of this market. According to the Indian Brand Equity Foundation (IBEF), the Indian government allocated USD 10.35 billion, and the Department of Health Research allocated USD 365.68 billion to promote the pharmaceutical sector in the Union Budget 2021–22. Additionally, as per the data published by the U.K. parliament in March 2022, the government declared R&D budget for 2022–25 was USD 41.9 million (EUR 39.8 billion). Under these plans, spending will rise from USD 5.3 million (EUR 5 billion) to USD 21.1 million (EUR 20 billion) annually from 2020 to 2025.